Precigen | 8-K: Current report
Precigen | 8-K: Current report
Precigen | 8-K: Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
Precigen | 8-K: Current report
Precigen | 8-K: Current report
Precigen | 8-K: Current report
Precigen | DEF 14A: Definitive information statements
Precigen | 8-K: Precigen Reports First Quarter 2024 Financial Results and Business Updates
Precigen | 8-K: Current report
Precigen | 8-K: Current report
Precigen | 8-K: Current report
Precigen | S-3: Registration statement for specified transactions by certain issuers
Precigen | 8-K: Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
Precigen | 8-K: Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025
Precigen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Precigen | 8-K: Current report
Precigen | 8-K: Precigen Reports First Quarter 2023 Financial Results and Business Updates
Precigen | DEFA14A: Others
Precigen | DEF 14A: Definitive proxy statements
Precigen | 8-K: Current report
No Data
No Data